Elisabetta
Elisabetta Abruzzese, Rome IT
| Patent application number | Description | Published |
|---|---|---|
| 20080249080 | Benzodiazepine Derivatives and Uses Thereof on Medical Field - The invention concerns benzodiazepine derivatives of formula | 10-09-2008 |
Elisabetta Arca, Dublin 2 IE
| Patent application number | Description | Published |
|---|---|---|
| 20140151611 | TRANSPARENT CONDUCTING OXIDE MATERIAL AND METHODS OF PRODUCING SAME - The invention relates to a new type of material and describes a novel material and way to improve the transparency of a transition metal oxide by employing an anionic doping strategy to modify the transparency. At the same time a cationic dopant is used to improve conductivity. | 06-05-2014 |
Elisabetta Bergantino, Cadoneghe IT
| Patent application number | Description | Published |
|---|---|---|
| 20110137036 | SYNTHESIS OF (4aS,7aS)-OCTAHYDRO-1H-PYRROLO[3,4-b]PYRIDINE - The present invention relates to the stereoselective synthesis of (4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine, as well as the conversion thereof, to give Moxifloxacin. Particularly, the present invention relates to a method for the synthesis of (4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine of formula (I) comprising: (a) the optical resolution by enzymatic hydrolysis of the intermediate dialkyl-1-alkylcarbonylpiperidine-2,3-dicarboxylate racemate of formula (II) to give, following isolation, the intermediate dialkyl-(2S,3R)-1-alkylcarbonyl-piperidine-2,3-dicarboxylate of formula (III) in which AIk is a straight or branched C1-C5 alkyl group; (b) the conversion of the intermediate (III) to (4aR,7aS)-1-alkylcarbonylhexahydrofuro[3,4-b]pyridine-5,7-dione of formula (IV) in which AIk has the meanings set forth above; (c) the conversion of the intermediate (IV) to (4aS,7as)-octahydro-1H-pyrrolo[3,4-b]pyridine of formula (I) with an optical purity above 99%. | 06-09-2011 |
| 20110207172 | PROCESS FOR THE PREPARATION OF TESTOSTERONE - The present invention relates to an industrial process for the reduction of 4-androstene-3,17-dione in order to obtain testosterone using a particularly stable and selective enzyme produced in a recombinant manner. | 08-25-2011 |
Elisabetta Chiarparin, Cambridge GB
| Patent application number | Description | Published |
|---|---|---|
| 20140179666 | BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY - The invention relates to bicyclic heterocycle compounds of formula (I): or tautomeric or stereochemically isomeric forms, N-oxides, pharmaceutically acceptable salts or the solvates thereof; wherein R | 06-26-2014 |
| 20150291586 | BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY - The invention relates to bicyclic heterocycle compounds of formula (I): | 10-15-2015 |
Elisabetta Flamini, Romsey GB
| Patent application number | Description | Published |
|---|---|---|
| 20130061205 | AUTOMATED GENERATION OF BRIDGING CODE TO AUGMENT A LEGACY APPLICATION USING AN OBJECT-ORIENTED LANGUAGE - A legacy machine-oriented language interface definition of a new module to be implemented within a legacy machine-oriented language application using an object-oriented language is received at a processor. An object-oriented class definition and bridging code that interfaces the object-oriented class definition to the legacy machine-oriented language interface definition is generated by the processor. An updated version of the object-oriented class definition is received that includes object-oriented code that implements functionality of the new module. A new version of the legacy machine-oriented language application is created that includes the new module as a new object accessible using the legacy machine-oriented language interface definition and as implemented by the object-oriented code in the updated version of the object-oriented class definition. | 03-07-2013 |
| 20140280607 | UPDATING AN E-MAIL RECIPIENT LIST - Arrangements describe herein relate to updating an e-mail recipient list. A first version of an e-mail can be received, the first version comprising a message header identifying at least a first e-mail recipient. The first version of the e-mail can be sent to the first e-mail recipient indicated in the message header. A second version of the e-mail can be received, the second version of the e-mail indicating at least a second e-mail recipient. The second version can be sent to the at least second e-mail recipient indicated in the message header of the second version. An update request for the first version can be received, the update request configured to be processed to update the message header of the first version to add the at least second e-mail recipient to the message header. The update request can be sent to the at least first e-mail recipient. | 09-18-2014 |
| 20150046552 | UPDATING AN E-MAIL RECIPIENT LIST - Arrangements describe herein relate to updating an e-mail recipient list. A first version of an e-mail can be received, the first version comprising a message header identifying at least a first e-mail recipient. The first version of the e-mail can be sent to the first e-mail recipient indicated in the message header. A second version of the e-mail can be received, the second version of the e-mail indicating at least a second e-mail recipient. The second version can be sent to the at least second e-mail recipient indicated in the message header of the second version. An update request for the first version can be received, the update request configured to be processed to update the message header of the first version to add the at least second e-mail recipient to the message header. The update request can be sent to the at least first e-mail recipient. | 02-12-2015 |
| 20150237041 | ATTRIBUTE-BASED ACCESS CONTROL - Attribute-based access control is performed across a first and a second security domain in a federated distributed processing environment. A security token received in the second security domain from a first service provider in the first security domain includes access control attributes. Access control information associated with a request to process an online transaction in the second security domain is received from an identity provider in the second security domain. The access control information is mapped into access control attributes compatible with a format of the access control attributes of the received security token. The mapped access control attributes are appended to the received security token to create a modified security token. The modified security token is signed with a certificate of a second service provider in the second security domain, and the modified security token is issued for consuming by any service provider in the second security domain. | 08-20-2015 |
| 20150244705 | IMPLEMENTING SINGLE SIGN-ON IN A TRANSACTION PROCESSING SYSTEM - A single sign-on is implemented in an online transaction processing system. A security token extracted from a transaction request is received. The security token is validated and, in response to a positive validation, security information is extracted. The security information is processed to validate the transaction request and a set of validation attributes is generated. The set of validation attributes is stored in a read-only data object. A transaction server is notified of the read-only data object to authorize processing of the transaction request by the transaction server. | 08-27-2015 |
Elisabetta Flamini, Eastleigh GB
| Patent application number | Description | Published |
|---|---|---|
| 20090255396 | SELF-ADJUSTING MUSIC SCROLLING SYSTEM - A system for automatically adjusting a music score comprises a display screen and a music scrolling system configured to perform the steps of selecting a music score, the music score being cataloged and stored in a music score database as a first MIDI file, displaying a first portion of the selected music score on the display screen, recording musical notes with a digital device, storing the recorded musical notes in memory as a WAV file, converting the WAV file into a second MIDI file, comparing the first MIDI file and the second MIDI file with a MIDI comparison algorithm, determining if the first MIDI file substantially matches the second MIDI file, automatically adjusting the music score on the display screen upon determining that the first MIDI file substantially matches the second MIDI file, and displaying one or more mistakes upon determining that the first MIDI file does not substantially match the second MIDI file. | 10-15-2009 |
| 20090299992 | METHODS AND SYSTEMS FOR IDENTIFYING DESIRED INFORMATION - A method of identifying desired objects of information determines whether an existing rule is appropriate to identify a new desired object of information, defines a new rule to include at least one search query string when one of the existing rules is not appropriate to identify the new desired object of information, and defines an initial new search query string to identify the new desired object of information, wherein the initial search query string has a search query string input value. Furthermore, the method includes identifying objects having an object value equal to the search query string input value, and identifying the objects as the results of the processing operation and as having an equivalence relationship with the initial search query string. When the results do not satisfy the new rule, subsequent search query strings are defined to form a search query string chain. | 12-03-2009 |
Elisabetta Frigimelica, Mogliano Veneto IT
| Patent application number | Description | Published |
|---|---|---|
| 20100183674 | COMPOSITIONS COMPRISING YERSINIA PESTIS ANTIGENS - Disclosed are several | 07-22-2010 |
Elisabetta Lubian, Zurich CH
| Patent application number | Description | Published |
|---|---|---|
| 20130309381 | Organic Compounds - A composition for masking the bitter taste of potassium chloride or other potassium salt used in a consumable product as a substitute, in whole or in part, for common table salt, said composition comprising a sugar alcohol and a compound of formula (I) | 11-21-2013 |
| 20140127144 | Flavour Modifying Compounds - A compound of formula (I) is used to modify the taste or flavour of a flavour composition or consumable product, | 05-08-2014 |
Elisabetta Marulli, Lecce IT
| Patent application number | Description | Published |
|---|---|---|
| 20100298195 | Composition - A composition comprises a bleaching catalyst admixed with an insoluble support matrix. | 11-25-2010 |
Elisabetta Messaggio, Milano (mi) IT
| Patent application number | Description | Published |
|---|---|---|
| 20130295100 | MARKERS FOR ACUTE KIDNEY INJURY AND USES THEREOF - The present invention relates to a method for predicting the risk of developing acute kidney injury in a subject from which a biological sample is obtained comprising: detecting the presence of at least one genomic single nucleotide polymorphism (SNP) selected from the group of: ADD1 rs4961 Trp [allelic genotype GT or TT], ADD2 rs4984 [allelic genotype CT or TT], HS-D3B1 rs2236780 [allelic genotype GG], LSS rs914247 [allelic genotype AA], MDR1 rs1045642 [allelic genotype TC or CC], SLC8A1 rs1 1893826 [allelic genotype AA], TRPC6 rs7925662 [allelic genotype CC] from said biological sample, wherein the presence of said allelic genotype is predictive of the risk of developing acute kidney injury. | 11-07-2013 |
Elisabetta Monaci, Siena IT
| Patent application number | Description | Published |
|---|---|---|
| 20090298099 | Gonococcal Proteins and Nucleic Acids - The invention provides proteins from gonococcus ( | 12-03-2009 |
Elisabetta Sartirana, Pavia IT
| Patent application number | Description | Published |
|---|---|---|
| 20160122241 | PROCESS FOR MANUFACTURING FLUOROPOLYMER COMPOSITES - The present invention pertains to a process for manufacturing a fluoropolymer composite, said process comprising the following sequential steps: (i) providing an aqueous latex comprising from 10% to 40% by weight, preferably from 15% to 35% by weight of at least one fluoropolymer comprising recurring units derived from vinylidene fluoride (VDF) [polymer (VDF)]; (ii) up-concentrating the aqueous latex provided in step (i) thereby providing an up-concentrated aqueous latex comprising from 45% to 60% by weight, preferably from 45% to 55% by weight of at least one polymer (VDF); (iii) contacting one continuous fibre or a bunch of continuous fibres with the up-concentrated aqueous latex provided in step (ii); (iv) squeezing the impregnated fibrous material provided in step (iii); (v) drying the squeezed fibrous material provided in step (iv), typically at a temperature comprised between 100° C. and 120° C.; (vi) baking the dried fibrous material provided in step (v) at a temperature comprised between 190° C. and 240° C.; (vii) cooling the coated fibrous material provided in step (vi), preferably to a temperature of about 20° C.; (viii) optionally, contacting the coated fibrous material provided in step (vii) with the up-concentrated aqueous latex provided in step (ii) and submitting the impregnated fibrous material so provided to sequential steps (iv) to (vii); and (ix) optionally, repeating step (viii) one or more times. The present invention also pertains to the fluoropolymer composite thereby provided and to uses of said fluoropolymer composite in various applications. | 05-05-2016 |
Elisabetta Spigone, Cambridge GB
| Patent application number | Description | Published |
|---|---|---|
| 20110221425 | APPARATUS AND ASSOCIATED METHODS - An analyte sensor apparatus and a corresponding fluid medium, | 09-15-2011 |
| 20140196522 | Apparatus and Associated Methods - An apparatus including first and second sensor elements, the first sensor element includes a first sensor material. The second sensor element includes a second sensor material. The first sensor material is configured such that an electrical property of the first sensor material is dependent upon the temperature of the environment in which the first and second sensor elements are located. The second sensor material is configured such that the same electrical property of the second sensor material is dependent upon the relative vapour pressure of a fluid in the environment in which the first and second sensor elements are located, the respective temperature and fluid relative vapour pressure dependencies of the first and second sensor materials allowing the temperature and fluid relative vapour pressure of the environment to be determined based on combined measurements of the electrical property of the first and second sensor materials in the environment. | 07-17-2014 |
| 20140197851 | APPARATUS AND ASSOCIATED METHODS - An apparatus including a sensor array, configured to produce an array output value in response to an environmental stimulus, and a controller, the sensor array including a plurality of sensors and a common output terminal connected to the respective outputs of the sensors, each sensor having first and second electrodes configured to output a respective sensor output value in a particular environment based on the areas of the first and second electrodes and/or the spacing therebetween, the controller configured to control which of the sensors are connected to the common output terminal using respective switches to vary the effective area and/or spacing of the sensor array such that the array output value at the common output terminal, based on the contribution of the respective sensor output values of the connected sensors, is held at a reference value. | 07-17-2014 |
Elisabetta Sporeno, Rome IT
| Patent application number | Description | Published |
|---|---|---|
| 20110217332 | Chimpanzee Adenovirus Vaccine Carriers - The present invention provides recombinant replication-defective adenoviral vectors derived from chimpanzee adenoviruses and methods for generating recombinant adenoviruses in human E1-expressing cell lines. The invention also provides compositions and methods suitable for use for the delivery and expression of transgenes encoding immunogens against which a boosted immune response is desired. The invention further provides methods of generating clinical grade vector stocks suitable for use in humans. In a particular embodiment the invention contemplates the use of vectors comprising transgenes which encode tumor associated antigens in vaccines and pharmaceutical compositions for the prevention and treatment of cancer. | 09-08-2011 |
| 20120328651 | CHIMPANZEE ADENOVIRUS VACCINE CARRIERS - The present invention provides recombinant replication-defective adenoviral vectors derived from chimpanzee adenoviruses and methods for generating recombinant adenoviruses in human E1-expressing cell lines. The invention also provides compositions and methods suitable for use for the delivery and expression of transgenes encoding immunogens against which a boosted immune response is desired. The invention further provides methods of generating clinical grade vector stocks suitable for use in humans. In a particular embodiment the invention contemplates the use of vectors comprising transgenes which encode tumor associated antigens in vaccines and pharmaceutical compositions for the prevention and treatment of cancer. | 12-27-2012 |
Elisabetta Surrenti, Firenze IT
| Patent application number | Description | Published |
|---|---|---|
| 20120226335 | INGESTIBLE CAPSULE FOR TREATING GASTRIC INFECTIONS, IN PARTICULAR FOR TREATING H. PYLORI INFECTIONS - The light capsule object of the present invention is an ingestible device designed to illuminate the gastric cavity of the stomach for therapeutic purposes directed against Helicobacter pylori (H. pylori) bacteria. It comprises: a casing transparent to visible light, in turn containing punctiform light sources, preferably constituted by LEDs, positioned immediately under said casing and capable of emitting light at appropriate wavelength bands (preferably 405 nm and 630 nm); a battery, adapted to power the LED sources for approximately 20-30 minutes (the average transit time in the stomach); a switch which allows a delayed power on and allows the tablet to be still “off” when it is swallowed. The light emitted by the capsule strikes the H. pylori bacteria anchored on the gastric wall. The light radiation is preferentially absorbed by molecules of porphyrin produced by the bacterium which works as photosensitizing agent by inducing the formation of cytotoxic molecular species. | 09-06-2012 |
Elisabetta Trezzi, Norfolk GB
| Patent application number | Description | Published |
|---|---|---|
| 20080279450 | Illuminant Estimation - A method of estimating, illuminant comprises minimising a Minkowski norm with illuminant constraints. The norm is preferably between 3 and 7 and most preferably between 4 and 6. The method is used to remove the colour of an illuminant from an image. | 11-13-2008 |
Elisabetta Verderio Edwards, Nottingham GB
| Patent application number | Description | Published |
|---|---|---|
| 20080305517 | Transglutaminase Crosslinked Collagen Biomaterial for Medical Implant Materials - The present invention provides a method for producing an improved biomaterial comprising treating a collagen biomaterial with a transglutaminase under conditions which permit the formation of cross-links within the collagen. Preferably, the transglutaminase is a tissue transglutaminase, a plasma transglutaminase or a microbial transglutaminase. In a preferred embodiment, the collagen biomaterial further comprises a cell adhesion factor, such as fibronectin. The invention further provides biomaterials obtainable by the methods of the invention, and medical implants and wound dressings comprising the same. | 12-11-2008 |